ATHA: Athira Pharma Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Athira Pharma Inc (ATHA).

OverviewDividends

$22.69M Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

ATHA Market Cap. (MRY)


ATHA Shares Outstanding (MRY)


ATHA Assets (MRY)


Total Assets

$58.78M

Total Liabilities

$13.94M

Total Investments

$2.84M

ATHA Income (MRY)


Revenue

$0

Net Income

-$96.94M

Operating Expense

$100.90M

ATHA Cash Flow (MRY)


CF Operations

-$97.17M

CF Investing

$54.83M

CF Financing

$194.00K

ATHA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$58,779,000 (-63.32%)

$160,245,000 (-37.93%)

$258,153,000 (-22.24%)

$332,008,000 (18.76%)

Assets Current

$54,841,000 (-64.56%)

$154,729,000 (-25.44%)

$207,533,000 (-20.42%)

$260,799,000 (35.59%)

Assets Non-Current

$3,938,000 (-28.61%)

$5,516,000 (-89.10%)

$50,620,000 (-28.91%)

$71,209,000 (-18.36%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$44,841,000 (-65.56%)

$130,188,000 (-44.63%)

$235,137,000 (-26.77%)

$321,084,000 (17.06%)

Property Plant & Equipment Net

$3,252,000 (-26.71%)

$4,437,000 (-16.53%)

$5,316,000 (1.90%)

$5,217,000 (45.52%)

Cash & Equivalents

$49,069,000 (-46.21%)

$91,215,000 (-5.36%)

$96,386,000 (-12.80%)

$110,537,000 (82.33%)

Accumulated Other Comprehensive Income

$1,000 (100.29%)

-$349,000 (82.16%)

-$1,956,000 (-404.12%)

-$388,000 (-1275.76%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$2,837,000 (-95.01%)

$56,835,000 (-61.91%)

$149,207,000 (-28.66%)

$209,158,000 (0.77%)

Investments Current

$2,837,000 (-95.01%)

$56,835,000 (-45.55%)

$104,378,000 (-27.12%)

$143,222,000 (15.45%)

Investments Non-Current

$0 (0%)

$0 (0%)

$44,829,000 (-32.01%)

$65,936,000 (-21.04%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$1,227,000 (-47.47%)

$2,336,000 (79.69%)

Trade & Non-Trade Payables

$319,000 (147.29%)

$129,000 (-94.84%)

$2,501,000 (341.09%)

$567,000 (-51.04%)

Accumulated Retained Earnings (Deficit)

-$406,146,000 (-31.35%)

-$309,206,000 (-61.44%)

-$191,534,000 (-99.73%)

-$95,895,000 (-133.65%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,217,000 (-23.22%)

$1,585,000 (-17.06%)

$1,911,000 (-0.47%)

$1,920,000 (92.00%)

Debt Current

$414,000 (12.50%)

$368,000 (12.88%)

$326,000 (13.19%)

$288,000 (132.26%)

Debt Non-Current

$803,000 (-34.02%)

$1,217,000 (-23.22%)

$1,585,000 (-2.88%)

$1,632,000 (86.30%)

Total Liabilities

$13,938,000 (-53.63%)

$30,057,000 (30.59%)

$23,016,000 (110.69%)

$10,924,000 (106.85%)

Liabilities Current

$13,135,000 (-54.46%)

$28,840,000 (34.57%)

$21,431,000 (130.64%)

$9,292,000 (110.94%)

Liabilities Non-Current

$803,000 (-34.02%)

$1,217,000 (-23.22%)

$1,585,000 (-2.88%)

$1,632,000 (86.30%)

ATHA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$26,093,000 (-21.65%)

$33,304,000 (2.31%)

$32,552,000 (53.34%)

$21,228,000 (216.41%)

Research & Development Expense

$70,682,000 (-24.64%)

$93,790,000 (52.59%)

$61,464,000 (43.63%)

$42,794,000 (222.10%)

Operating Expenses

$100,902,000 (-19.58%)

$125,466,000 (20.62%)

$104,016,000 (62.47%)

$64,022,000 (220.19%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$96,940,000 (17.62%)

-$117,672,000 (-23.04%)

-$95,639,000 (-74.36%)

-$54,853,000 (-174.88%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$96,940,000 (17.62%)

-$117,672,000 (-23.04%)

-$95,639,000 (-74.36%)

-$54,853,000 (-174.88%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$96,940,000 (17.62%)

-$117,672,000 (-23.04%)

-$95,639,000 (-74.36%)

-$54,853,000 (-174.88%)

Weighted Average Shares

$38,480,875 (1.21%)

$38,020,182 (0.76%)

$37,733,240 (2.20%)

$36,921,172 (208.53%)

Weighted Average Shares Diluted

$38,480,875 (1.21%)

$38,020,182 (0.76%)

$37,733,240 (2.20%)

$36,921,172 (208.53%)

Earning Before Interest & Taxes (EBIT)

-$96,940,000 (17.62%)

-$117,672,000 (-23.04%)

-$95,639,000 (-74.36%)

-$54,853,000 (-174.88%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$100,902,000 (19.58%)

-$125,466,000 (-20.62%)

-$104,016,000 (-62.47%)

-$64,022,000 (-220.19%)

ATHA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$54,830,000 (-42.34%)

$95,089,000 (64.90%)

$57,664,000 (1513.68%)

-$4,079,000 (98.06%)

Net Cash Flow from Financing

$194,000 (-60.65%)

$493,000 (-24.62%)

$654,000 (-99.33%)

$97,089,000 (-66.84%)

Net Cash Flow from Operations

-$97,170,000 (3.56%)

-$100,753,000 (-39.03%)

-$72,469,000 (-68.15%)

-$43,098,000 (-78.73%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$42,146,000 (-715.05%)

-$5,171,000 (63.46%)

-$14,151,000 (-128.35%)

$49,912,000 (-14.78%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$54,863,000 (-42.49%)

$95,393,000 (62.22%)

$58,805,000 (2446.57%)

-$2,506,000 (98.79%)

Capital Expenditure

-$33,000 (89.14%)

-$304,000 (73.36%)

-$1,141,000 (27.46%)

-$1,573,000 (32.20%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$194,000 (-60.65%)

$493,000 (-24.62%)

$654,000 (-99.33%)

$97,089,000 (-53.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$11,049,000 (4.01%)

$10,623,000 (0.16%)

$10,606,000 (129.42%)

$4,623,000 (630.33%)

Depreciation Amortization & Accretion

$1,211,000 (2.37%)

$1,183,000 (12.88%)

$1,048,000 (65.30%)

$634,000 (31600.00%)

ATHA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-132.60% (-91.90%)

-69.10% (-95.20%)

-35.40% (-121.25%)

-16.00% (-1.91%)

Return on Average Assets (ROAA)

-99.50% (-66.11%)

-59.90% (-78.27%)

-33.60% (-115.38%)

-15.60% (-9.86%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-2613.80% (-1405.65%)

-173.60% (-216.21%)

-54.90% (-126.86%)

-24.20% (-30.81%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.23 (70.36%)

-0.79 (37.27%)

-1.25 (85.67%)

-8.74 (57.36%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.51 (-28.73%)

0.71 (39.22%)

0.51 (-66.36%)

1.52 (-62.62%)

Debt to Equity Ratio (D/E)

0.31 (34.63%)

0.23 (135.71%)

0.1 (188.24%)

0.03 (78.95%)

Earnings Per Share (EPS)

-2.52 (18.45%)

-3.09 (-22.13%)

-2.53 (-69.80%)

-1.49 (10.78%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.53 (4.97%)

-2.66 (-36.24%)

-1.95 (-61.24%)

-1.21 (45.22%)

Book Value Per Share (BVPS)

1.17 (-65.98%)

3.42 (-45.06%)

6.23 (-28.33%)

8.7 (-62.06%)

Tangible Assets Book Value Per Share (TABVPS)

1.53 (-63.77%)

4.21 (-38.40%)

6.84 (-23.91%)

8.99 (-61.51%)

Enterprise Value Over EBIT (EV/EBIT)

1 (0%)

0 (0%)

0 (0%)

-7 (85.42%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.56 (286.11%)

0.14 (139.34%)

-0.37 (94.80%)

-7.03 (85.20%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

4.17 (-22.18%)

5.37 (-44.60%)

9.68 (-65.50%)

28.07 (-35.72%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$97,203,000 (3.81%)

-$101,057,000 (-37.29%)

-$73,610,000 (-64.78%)

-$44,671,000 (-69.00%)

Enterprise Value (EV)

-$53,227,855 (-216.45%)

-$16,820,363 (-148.55%)

$34,647,897 (-90.91%)

$381,343,885 (-59.77%)

Earnings Before Tax (EBT)

-$96,940,000 (17.62%)

-$117,672,000 (-23.04%)

-$95,639,000 (-74.36%)

-$54,853,000 (-174.88%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$95,729,000 (17.82%)

-$116,489,000 (-23.15%)

-$94,591,000 (-74.46%)

-$54,219,000 (-171.73%)

Invested Capital

-$2,208,000 (-105.29%)

$41,775,000 (-70.63%)

$142,247,000 (-33.56%)

$214,099,000 (-0.67%)

Working Capital

$41,706,000 (-66.87%)

$125,889,000 (-32.35%)

$186,102,000 (-26.01%)

$251,507,000 (33.83%)

Tangible Asset Value

$58,779,000 (-63.32%)

$160,245,000 (-37.93%)

$258,153,000 (-22.24%)

$332,008,000 (18.76%)

Market Capitalization

$22,687,145 (-75.47%)

$92,472,637 (-22.89%)

$119,918,897 (-75.36%)

$486,684,885 (-56.26%)

Average Equity

$73,125,250 (-57.05%)

$170,264,000 (-36.94%)

$269,982,000 (-21.24%)

$342,811,750 (169.34%)

Average Assets

$97,434,000 (-50.40%)

$196,441,250 (-30.91%)

$284,337,750 (-19.27%)

$352,219,250 (150.02%)

Invested Capital Average

$3,708,750 (-94.53%)

$67,771,000 (-61.13%)

$174,342,750 (-23.24%)

$227,132,500 (110.36%)

Shares

38,669,073 (1.61%)

38,054,583 (0.60%)

37,829,305 (1.28%)

37,351,104 (14.98%)